Starling Oncology, Inc. Net Income (Loss) Available to Common Stockholders, Basic
Starling Oncology, Inc. (STLN) reported Net Income (Loss) Available to Common Stockholders, Basic of -$8.24 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-06
- Starling Oncology, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$8.24M.
- Starling Oncology, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$2.09M.
- Starling Oncology, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$6.43M.
- Starling Oncology, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$13.77M.
- Starling Oncology, Inc. net income (loss) available to common stockholders, basic for fiscal 2025 was -$50.30M.
- Starling Oncology, Inc. net income (loss) available to common stockholders, basic for fiscal 2024 was -$53.01M.
- Starling Oncology, Inc. net income (loss) available to common stockholders, basic for fiscal 2023 was -$67.88M, a 99919.12% decline from fiscal 2022.
- Starling Oncology, Inc. net income (loss) available to common stockholders, basic for fiscal 2022 was $68.00K.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$8.24M 10-Q · filed 2026-08-06 | -$10.33M 10-Q · filed 2026-08-06 | -$16.76M derived: sum of 3 quarters · filed 2026-08-06 | -$30.53M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$2.09M 10-Q · filed 2026-05-07 | -$8.52M derived: sum of 2 quarters · filed 2026-05-07 | -$22.29M derived: sum of 3 quarters · filed 2026-05-07 | -$36.28M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$6.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$20.20M derived: sum of 2 quarters · filed 2026-03-12 | -$34.19M derived: sum of 3 quarters · filed 2026-08-06 | -$50.30M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$13.77M 10-Q · filed 2025-11-13 | -$27.76M derived: sum of 2 quarters · filed 2026-08-06 | -$43.88M 10-Q · filed 2025-11-13 | -$54.66M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$13.99M 10-Q · filed 2026-08-06 | -$30.07M 10-Q · filed 2026-08-06 | -$40.89M derived: sum of 3 quarters · filed 2026-08-06 | -$54.12M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$16.07M 10-Q · filed 2026-05-07 | -$26.90M derived: sum of 2 quarters · filed 2026-05-07 | -$40.12M derived: sum of 3 quarters · filed 2026-05-07 | -$52.80M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$10.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$24.05M derived: sum of 2 quarters · filed 2026-03-12 | -$36.73M derived: sum of 3 quarters · filed 2026-03-12 | -$53.01M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$13.22M 10-Q · filed 2025-11-13 | -$25.90M derived: sum of 2 quarters · filed 2025-11-13 | -$42.18M 10-Q · filed 2025-11-13 | -$57.46M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$12.68M 10-Q · filed 2025-08-13 | -$28.95M 10-Q · filed 2025-08-13 | -$44.24M derived: sum of 3 quarters · filed 2025-08-13 | -$58.51M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$16.27M 10-Q · filed 2025-05-14 | -$31.56M derived: sum of 2 quarters · filed 2025-05-14 | -$45.83M derived: sum of 3 quarters · filed 2025-05-14 | -$59.65M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$15.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$29.56M derived: sum of 2 quarters · filed 2025-03-26 | -$43.38M derived: sum of 3 quarters · filed 2025-03-26 | -$67.88M 10-K · filed 2025-03-26 |
| 2023-09-30 | -$14.27M 10-Q · filed 2024-11-13 | -$28.09M derived: sum of 2 quarters · filed 2024-11-13 | -$52.59M 10-Q · filed 2024-11-13 | -$61.32M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$13.82M 10-Q · filed 2024-08-13 | -$38.32M 10-Q · filed 2024-08-13 | -$47.05M derived: sum of 3 quarters · filed 2024-08-13 | -$49.23M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$24.49M 10-Q · filed 2024-05-14 | -$33.23M derived: sum of 2 quarters · filed 2024-05-14 | -$35.41M derived: sum of 3 quarters · filed 2024-05-14 | -$39.91M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$8.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$10.91M derived: sum of 2 quarters · filed 2024-03-28 | -$15.42M derived: sum of 3 quarters · filed 2024-03-28 | $68.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$2.17M 10-Q · filed 2023-11-08 | -$6.68M derived: sum of 2 quarters · filed 2023-11-08 | $8.80M 10-Q · filed 2023-11-08 | -$769.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$4.50M 10-Q · filed 2023-08-09 | $11.25M 10-Q · filed 2023-08-09 | $1.41M derived: sum of 3 quarters · filed 2023-08-09 | -$1.57M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $15.77M 10-Q · filed 2023-05-10 | $5.91M derived: sum of 2 quarters · filed 2023-05-10 | $2.93M derived: sum of 3 quarters · filed 2023-05-10 | $6.13M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$9.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$12.84M derived: sum of 2 quarters · filed 2023-03-16 | -$9.63M derived: sum of 3 quarters · filed 2023-03-16 | -$10.63M 10-K · filed 2023-03-16 |
| 2021-09-30 | -$2.98M 10-Q · filed 2022-11-09 | $225.00K derived: sum of 2 quarters · filed 2022-11-09 | -$771.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $3.21M 10-Q · filed 2022-08-09 | $2.21M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | -$996.00K 10-Q · filed 2022-05-10 |